igf-1 lr3 clinical trial humans Recombinant Human IGF-I/IGF-1 GMP Protein, CF 8335D-GMP: R&D Systems IGF-1 LR3 Receptor Grade 1mg
Description
These findings indicate that HT29 cells, as many other cancer cell lines according to the literature, are highly susceptible to the effects of MGL, that is, to the depletion of methionine, more than non-malignant cells
Hoffman, R.L
This condition can also worsen and cause serious damage
Most likely other host defences than glutathione are strengthened by cystine
doi: 10.3389/fphar.2021.750380 42 ErdalMSahinMHasimiAUckayaGKutluMSaglamK
Springer Link 10:122
